glp 1/gip receptor agonist GLP1-GIP co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Effects, working principles and target

Bifidobacterium infantis produces the postbiotic acetate, and interacts with Akkermansia and Butyricum to promote an ecosystem in the gut that naturally boosts GLP-1

Type 2 Diabetes Mellitus (T2DM) is one of the most common metabolic disorders worldwide

Both glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium-glucose cotransporter-2 (SGLT-2) inhibitors can reduce CV risk in patients with T2D, and both are recommended by the American Diabetes Association to reduce the risk of major cardiovascular events (MACE)

Example code lists used to identify covariates are included in supplementary table S2

World Health Organization

But does it balance cost and safety, or just look good on the surface